Idexx Laboratories: A Strong Buy Amidst Veterinary Healthcare Market ResilienceWe continue to view the veterinary healthcare market as a relative safe haven investment area for investors, and we believe the industry is fairly recession resilient (i.e., largely inelastic demand, solid pricing power, and favorable demographic trends) and lacks many of the investment risks present in the human healthcare space. Given the above, we have conviction in the company’s management team, long- term organic growth trajectory, and business franchise overall; thus, we view Idexx as a core long-term holding and reiterate our Outperform rating on the stock.